Role of Cannabinoids and Endocannabinoids in Cerebral Ischemia

Overview

Journal Curr Pharm Des

Publisher Bentham Science Publishers

Date 2008 Sep 11

PMID 18781985

Citations 43

Authors

Cecilia J Hillard

Affiliations

Soon will be listed here.

Abstract

The human costs of stroke are very large and growing; it is the third largest cause of death in the United States and survivors are often faced with loss of ability to function independently. There is a large need for therapeutic approaches that act to protect neurons from the injury produced by ischemia and reperfusion. The goal of this review is to introduce and discuss the available data that endogenous cannabinoid signaling is altered during ischemia and that it contributes to the consequences of ischemia-induced injury. Overall, the available data suggest that inhibition of CB1 receptor activation together with increased CB2 receptor activation produces beneficial effects.

Citing Articles

Potential of CBD Acting on Cannabinoid Receptors CB and CB in Ischemic Stroke.

Raich I, Lillo J, Rivas-Santisteban R, Rebassa J, Capo T, Santandreu M Int J Mol Sci. 2024; 25(12).

PMID: 38928415 PMC: 11204117. DOI: 10.3390/ijms25126708.

Cannabis, Cannabinoids, and Stroke: Increased Risk or Potential for Protection-A Narrative Review.

Carter C, Laviolette L, Bietar B, Zhou J, Lehmann C Curr Issues Mol Biol. 2024; 46(4):3122-3133.

PMID: 38666926 PMC: 11048784. DOI: 10.3390/cimb46040196.

Beta-Caryophyllene, a Cannabinoid Receptor Type 2 Selective Agonist, in Emotional and Cognitive Disorders.

Ricardi C, Barachini S, Consoli G, Marazziti D, Polini B, Chiellini G Int J Mol Sci. 2024; 25(6).

PMID: 38542177 PMC: 10970213. DOI: 10.3390/ijms25063203.

Hippocampal expression of the cannabinoid receptor type 1 in canine epilepsy.

Kostic D, Nowakowska M, Freundt Revilla J, Attig F, Rohn K, Gualtieri F Sci Rep. 2023; 13(1):3138.

PMID: 36823232 PMC: 9950490. DOI: 10.1038/s41598-023-29868-3.

Treadmill Exercise Prevents Cognitive Impairments in Adolescent Intermittent Ethanol Rats by Reducing the Excessive Activation of Microglia Cell in the Hippocampus.

Guo Y, Yan M, Li L, Zhao L, Li Y Int J Mol Sci. 2022; 23(23).

PMID: 36499029 PMC: 9740642. DOI: 10.3390/ijms232314701.

References

Marinelli S, Vaughan C, Christie M, Connor M . Capsaicin activation of glutamatergic synaptic transmission in the rat locus coeruleus in vitro. J Physiol. 2002; 543(Pt 2):531-40. PMC: 2290516. DOI: 10.1113/jphysiol.2002.022863. View

Zhuang S, Kittler J, Grigorenko E, Kirby M, Sim L, Hampson R . Effects of long-term exposure to delta9-THC on expression of cannabinoid receptor (CB1) mRNA in different rat brain regions. Brain Res Mol Brain Res. 1998; 62(2):141-9. DOI: 10.1016/s0169-328x(98)00232-0. View

Hillard C, Manna S, Greenberg M, DiCamelli R, Ross R, Stevenson L . Synthesis and characterization of potent and selective agonists of the neuronal cannabinoid receptor (CB1). J Pharmacol Exp Ther. 1999; 289(3):1427-33. View

Kempe K, Hsu F, Bohrer A, Turk J . Isotope dilution mass spectrometric measurements indicate that arachidonylethanolamide, the proposed endogenous ligand of the cannabinoid receptor, accumulates in rat brain tissue post mortem but is contained at low levels in or is absent from fresh.... J Biol Chem. 1996; 271(29):17287-95. DOI: 10.1074/jbc.271.29.17287. View

Krieger D, Yenari M . Therapeutic hypothermia for acute ischemic stroke: what do laboratory studies teach us?. Stroke. 2004; 35(6):1482-9. DOI: 10.1161/01.STR.0000126118.44249.5c. View

Ashton J, Rahman R, Nair S, Sutherland B, Glass M, Appleton I . Cerebral hypoxia-ischemia and middle cerebral artery occlusion induce expression of the cannabinoid CB2 receptor in the brain. Neurosci Lett. 2006; 412(2):114-7. DOI: 10.1016/j.neulet.2006.10.053. View

Hussain M, Shuaib A . Research into neuroprotection must continue ... But with a different approach. Stroke. 2008; 39(2):521-2. DOI: 10.1161/STROKEAHA.107.494781. View

Novak V, Chowdhary A, FARRAR B, Nagaraja H, Braun J, Kanard R . Altered cerebral vasoregulation in hypertension and stroke. Neurology. 2003; 60(10):1657-63. DOI: 10.1212/01.wnl.0000068023.14587.06. View

Maresz K, Pryce G, Ponomarev E, Marsicano G, Croxford J, Shriver L . Direct suppression of CNS autoimmune inflammation via the cannabinoid receptor CB1 on neurons and CB2 on autoreactive T cells. Nat Med. 2007; 13(4):492-7. DOI: 10.1038/nm1561. View

10.

Felder C, Joyce K, Briley E, Glass M, Mackie K, Fahey K . LY320135, a novel cannabinoid CB1 receptor antagonist, unmasks coupling of the CB1 receptor to stimulation of cAMP accumulation. J Pharmacol Exp Ther. 1998; 284(1):291-7. View

11.

Clement A, Hawkins E, Lichtman A, Cravatt B . Increased seizure susceptibility and proconvulsant activity of anandamide in mice lacking fatty acid amide hydrolase. J Neurosci. 2003; 23(9):3916-23. PMC: 6742184. View

12.

Schabitz W, Giuffrida A, Berger C, Aschoff A, Schwaninger M, Schwab S . Release of fatty acid amides in a patient with hemispheric stroke: a microdialysis study. Stroke. 2002; 33(8):2112-4. DOI: 10.1161/01.str.0000023491.63693.18. View

13.

Caulfield M, Brown D . Cannabinoid receptor agonists inhibit Ca current in NG108-15 neuroblastoma cells via a pertussis toxin-sensitive mechanism. Br J Pharmacol. 1992; 106(2):231-2. PMC: 1907498. DOI: 10.1111/j.1476-5381.1992.tb14321.x. View

14.

Mendizabal V, Adler-Graschinsky E . Cannabinoids as therapeutic agents in cardiovascular disease: a tale of passions and illusions. Br J Pharmacol. 2007; 151(4):427-40. PMC: 2013961. DOI: 10.1038/sj.bjp.0707261. View

15.

Parmentier-Batteur S, Jin K, Mao X, Xie L, Greenberg D . Increased severity of stroke in CB1 cannabinoid receptor knock-out mice. J Neurosci. 2002; 22(22):9771-5. PMC: 6757835. View

16.

Andersson M, JACOBSSON S, Jonsson K, Tiger G, Fowler C . Neurotoxicity of glutamate in chick telencephalon neurons: reduction of toxicity by preincubation with carbachol, but not by the endogenous fatty acid amides anandamide and palmitoylethanolamide. Arch Toxicol. 2000; 74(3):161-4. DOI: 10.1007/s002040050669. View

17.

Haavik C, HARDMAN H . Hypothermic action of delta 9-tetrahydrocannabinol, 11-hydroxy-delta 9-tetrahydrocannabinol and 11-hydroxy-delta 8-tetrahydrocannabinol in mice. Life Sci. 1973; 13(12):1771-8. DOI: 10.1016/0024-3205(73)90124-0. View

18.

De Petrocellis L, Bisogno T, Maccarrone M, Davis J, Finazzi-Agro A, Di Marzo V . The activity of anandamide at vanilloid VR1 receptors requires facilitated transport across the cell membrane and is limited by intracellular metabolism. J Biol Chem. 2001; 276(16):12856-63. DOI: 10.1074/jbc.M008555200. View

19.

Mehta S, Manhas N, Raghubir R . Molecular targets in cerebral ischemia for developing novel therapeutics. Brain Res Rev. 2007; 54(1):34-66. DOI: 10.1016/j.brainresrev.2006.11.003. View

20.

MacGregor D, Carswell H, Graham D, McCulloch J, Macrae I . Impaired cerebral autoregulation 24 h after induction of transient unilateral focal ischaemia in the rat. Eur J Neurosci. 2000; 12(1):58-66. DOI: 10.1046/j.1460-9568.2000.00880.x. View